Larvol Delta - A-phase-1-dose-escalation-study-of-the-oncolytic-adenovirus-enadenotucirev-administered-intravenously-to-patients-with-epithelial-solid-tumors-EVOLVE

enadenotucirev (ColoAd1) - PsiOxus

http://www.ncbi.nlm.nih.gov/pubmed/30691536

Jan 30, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next